IRCT20160919029871N3 IRCT 2018-03-02 Guilan University of Medical Sciences Topical nonsteroidal anti-inflammatory drug effect on patients with pseudoexfoliation syndrome during cataract surgery The role of topical NSAIDs on inflammation and anterior segment complications after cataract surgery in patients with pseudoexfoliation syndrome 2018-01-21 anticipated 96 Complete https://irct.ir/trial/28593 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients with cataract and clinical signs of PEX are randomly assigned into 2 groups through block randomization using blocks of size 4. Group 1: all medication in group 1 plus eye drop Ketorolac every 6 hours until 2 weeks. Group 2: Betamethasone eye drops every 4 hours and Chlobiotic every 6 hours, Blinding description: Addition of ketorolac eye drops will not be explained to the patient. 3 Anterior segment inflammation and complications after cataract surgery in patients with pseudoexfoliation syndrome. Intervention 1: Interventional Group: In addition to routine care including chloramphenicol eye drops every 6 hours and betamethasone eye drops every 4 hours until one month after surgery, ketorolac (Sinarolac 0.5%) is taken every 6 hours for 15 days. Intervention 2: Control Group: Patients who receive routine care including chloramphenicol eye drops every 6 hours and betamethasone eye drops every 4 hours until one month after surgery. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information